LETTER TO THE EDITOR
Quantitative measurement of circulating lymphoid-specific helicase (HELLS) gene transcript: a potential serum biomarker for melanoma metastasis
Version of Record online: 28 SEP 2010
© 2010 John Wiley & Sons A/S
Pigment Cell & Melanoma Research
Volume 23, Issue 6, pages 845–848, December 2010
How to Cite
Kim, H.-E., Symanowski, J. T., Samlowski, E. E., Gonzales, J. and Ryu, B. (2010), Quantitative measurement of circulating lymphoid-specific helicase (HELLS) gene transcript: a potential serum biomarker for melanoma metastasis. Pigment Cell & Melanoma Research, 23: 845–848. doi: 10.1111/j.1755-148X.2010.00753.x
- Issue online: 13 OCT 2010
- Version of Record online: 28 SEP 2010
- Accepted manuscript online: 18 AUG 2010 10:52AM EST
Table S1. Comparison of melanoma patient characteristics between AJCC stage 0/I and stage IV groups used in the supervised analysis serum samples.
Table S2. anova results comparing individual gene transcript between the local and metastatic groups.
Appendix S1. Materials and Methods.
|PCMR_753_sm_AppS1.doc||35K||Supporting info item|
|PCMR_753_sm_TableS1.doc||28K||Supporting info item|
|PCMR_753_sm_TableS2.doc||29K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.